Results
|
|
5641.
|
|
|
|
5642.
|
|
|
|
5643.
|
|
|
|
5644.
|
|
|
|
5645.
|
|
|
|
5646.
|
|
|
|
5647.
|
|
|
|
5648.
|
|
|
|
5649.
|
|
|
|
5650.
|
|
|
|
5651.
|
|
|
|
5652.
|
The POWER-tool: Recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design. [electronic resource] by
- Gaasterland, C M W
- Jansen-van der Weide, M C
- Vroom, E
- Leeson-Beevers, K
- Kaatee, M
- Kaczmarek, R
- Bartels, B
- van der Pol, W L
- Roes, K C B
- van der Lee, J H
Producer: 20190528
In:
Health policy (Amsterdam, Netherlands) vol. 122
Availability: No items available.
|
|
|
5653.
|
|
|
|
5654.
|
|
|
|
5655.
|
|
|
|
5656.
|
|
|
|
5657.
|
|
|
|
5658.
|
|
|
|
5659.
|
|
|
|
5660.
|
|